Endocrine Abstracts

Background: Copeptin is used as a diagnostic marker for acute myocardial infarction, adrenomedullin as a prognostic marker for congestive heart failure. Both hormones may be involved in pathophysiology of metabolic syndrome.Methods: We have used sera of the ‘Silent diabetes study’ (1). Sera of 920 patients were eligible for this analysis. All patients underwent an oral glucose tolerance test, patients with previously known diabetes were exclude...